Dr. Alexandra Duncan

Dr. Duncan (DrPH, Sociomedical Sciences, Columbia University Mailman School of Public Health; MPH, Community Health, Tulane University School of Public Health and Tropical Medicine) has post-doctoral training (Johns Hopkins University Bloomberg School of Public Health) in drug dependence and HIV epidemiology, with a focus on multi-level modeling, longitudinal analysis, and environmental factors associated with substance use.

Much of Dr. Duncan’s research has focused on longitudinal analysis of substance abuse prevention interventions; the impact of substance abuse treatment program organizational factors on client-level residential substance abuse treatment outcomes; substance use and HIV surveillance; racial/ethnic disparities in the access to and quality of substance abuse treatment and HIV/AIDS treatment; and the evaluation of health programs. While at IMPAQ, Dr. Duncan has been the Task Lead on several projects for the Center for Consumer Information and Insurance Oversight (CCIIO) at the Centers for Medicare and Medicaid Services (CMS). These projects include Interim Task Lead for Data Integrity Tool automated email generation process to identify errors in State and Issuer insurance plans for the Affordable Care Act (ACA) Marketplace; Task Lead for Year Clinical Appropriates Assessment Review for 2016 Qualified Health Plan certification to ensure Issuers have clinically appropriate medications for specified medical conditions; Task Lead for the Treatment Protocol Calculator that will provide an aggregate consumer out of pocket cost for specified medical conditions; and Task Lead for testing the 2016 Actuarial Value Calculator. Additionally, Dr. Duncan is a member of the Plan Preview team to review Issuer ACA Marketplace insurance plan details and compliance

Prior to coming to IMPAQ, Dr. Duncan worked at several academic institutions on research studies related to substance use and HIV prevention, conducted focus groups, and analyzed qualitative data; conducted quantitative on the analysis the use and quality of HIV care, treatment, and housing services for consumers of HIV-related services; worked at several non-profit organizations on HIV prevention interventions, instrument development, and evaluation health programs; and worked in government contracting with NIH, CDC, SAMHSA, and HRSA clients.

IMPAQ Papers and Presentations

Duncan, A. (2015, June). Cautious use of race in analyses to predict retention in substance abuse treatment. Presentation at the College on Problems of Drug Dependence's 77th Annual Scientific Meeting, Phoenix, AZ.

Duncan, A., Melnick, G., Ahmed, R. & Furr-Holden, C. D. (2014). Post-treatment drug use abstinence: Does the majority program clientele matter? Journal of Ethnicity in Substance Abuse. 13(3), 185-208.

Duncan, A., Van Devanter, N., Ahmed, R., Burrell-Piggott, T. & Furr-Holden, C. D. (2014). The role of substance use in adherence to HIV medication and medical appointments. Journal of the Association of Nurses in AIDS Care, 25(3), 262-268.

Furr-Holden, C. D., Lee, M. H., Johnson, R., Milam, A. J., Duncan, A., Reboussin, B. A., Leaf, P.J. & Ialongo, N. S. (2015). Neighborhood environment and marijuana use in urban young adults. Prevention Science, 16(2), 268-278.